Melpomeni Fani

Prof. Dr. phil.
Melpomeni Fani

Position(s)
Division Head Radiopharmaceutical Chemistry
Clinic of Radiology and Nuclear Medicine

 

Institution
University Hospital Basel

Phone +41 61 556 58 91

Email

 

Research Focus

Oncology & Hematology

Area of Research

Development of targeted radiopharmaceuticals for oncological indications in preclinical and clinical settings


Approved Research Projects

-


    Collaborations

    National Collaborations

    • Prof. Damian Wild, Division of Nuclear Medicine, University Hospital Basel
    • Prof. Emanuel Christ, Endocrinology, Diabetology and Metabolism, University Hospital Basel
    • Prof. Daniel Ricklin, Molecular Pharmacy, Department of Pharmaceutical Sciences, University of Basel
    • Prof. Thomas Ward, Artificial Metalloenzymes Laboratory, Department of Chemistry, University of Basel
    • Dr. Salvatore Piscuoglio, Research Department Pathology, Department of Biomedicine, University of Basel
    • PD Dr. Eric Grouzmann, Catecholamines and Peptides, Centre Hospitalier Universitaire Vaudois (CHUV)
    • Dr. Martin Béhé, Center for Radiopharmaceutical Sciences, Paul Scherrer Institut (PSI)


    International Collaborations

    • Prof. Jan Münch, Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany
    • Prof. Stefan Schulz, Institute of Pharmacology and Toxicology, University Hospital Jena, Jena, Germany
    • Prof. Franck Denat, Institute of Molecular Chemistry, University of Burgundy, Dijon, France
    • Prof. Ali Azhdarinia, Center for Precision Biomedicine, McGovern Medical School, University of Texas, Houston TX, USA
    • EU consortium ERAPerMed (Prof. Alicja Hubalewska-Dydejczyk, Jagiellonian University, Kraków, Poland; Prof. Clemens Decristoforo, Innsbruck Medical University, Austria; PD Renata Mikolajczak, National Centre for Nuclear Research, Otwock, Poland; Dr. Petra Kolenc Peitl, University Medical Centre Ljubljana, Slovenia)

     


    Ongoing Research Projects

    1.    “Development of a new class of radiopharmaceuticals for diagnosis and therapy of CXCR4-expressing malignancies based on the endogenous CXCR4 antagonist EPI-X4”, SNF Schweizerischer Nationalfonds, 07.2020-06.2023 (PI)

    2.    “New PET Tracers established on a novel Cu-61 Platform”, Innosuisse, 11.2020-10.2022 (PI)

    3.    “A theranostic approach for augmenting the diagnostic and therapeutic efficacy in neuroendocrine tumours and other somatostatin”, Industrial funding, 05.2020-04.2022 (PI)

    4.    “Enhancing monoamine transporters expression in neuroendocrine tumors to improve radionuclide imaging and therapy”, SNF Schweizerischer Nationalfonds, 11.2017-04.2021 (collaborator)

    5.    “Epigenetic regulation to improve imaging and therapy of neuroendocrine tumours with ST8950 a new SSTR2/SSTR5 agonist”. Innosuisse, 07.2021-06.2023 (collaborator)


    Research Team

    Dr. Rosalba Mansi

    Research Fellow

    Phone +41 61 328 56 28
    Email

    Luigi Del Pozzo

    Research Fellow

    Phone +41 61 328 56 28
    Email

    Dr. Raghuvir Haridas Gaonkar

    Research Fellow

    Phone +41 61 328 56 28
    Email

    Petra Türkauf-Frei

    Research Fellow

    Phone +41 61 265 46 71
    Email

    Tais Basaco Bernabeu

    Research Fellow

    Phone +41 61 328 56 28
    Email